Contextualising cox-2 selective and non-selective NSAID risk - Providing a background for understanding risks of medical treatments

Contextualising cox-2 selective and non-selective NSAID risk - Providing a background for understanding risks of medical treatments

Bibliografski detalji
Glavni autori:	Moore, A, Derry, S
Format:	Conference item
Izdano:	2006

Slični predmeti

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs.
od: Moore, R, i dr.
Izdano: (2008)

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
od: Moore, R, i dr.
Izdano: (2008)

Calculating the balance of gastrointestinal and cardiovascular risk with combs and nsaids
od: Moore, A, i dr.
Izdano: (2006)

Comparison Between Two NSAIDs (Non selective & selective COX-2 Inhibitor) According to their Renal Toxicity on Elderly People
od: Haydar F. Hadi
Izdano: (2007-06-01)

Gastric and renal effects of COX-2 selective and non-selective NSAIDs in rats receiving low-dose aspirin therapy
od: Marcella Goetz MORO, i dr.

New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation
od: Riham M. Bokhtia, i dr.
Izdano: (2023-02-01)

Gastrointestinal harm from NSAIDs: An operations research approach
od: Moore, A, i dr.
Izdano: (2006)

Topical NSAIDs for chronic musculoskeletal pain in adults.
od: Derry, S, i dr.
Izdano: (2012)

Topical NSAIDs for chronic musculoskeletal pain in adults.
od: Derry, S, i dr.
Izdano: (2012)

Topical NSAIDs for acute pain in adults
od: Massey, T, i dr.
Izdano: (2010)

Topical NSAIDs for acute pain in adults.
od: Massey, T, i dr.
Izdano: (2010)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
od: Moore, R, i dr.
Izdano: (2006)

Topical NSAIDS for chronic musculoskeletal pain in adults
od: Derry, S, i dr.
Izdano: (2009)

Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors
od: U Klotz
Izdano: (2005-03-01)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
od: Alaa Rostom, i dr.
Izdano: (2009-10-01)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
od: Phillips Ceri J, i dr.
Izdano: (2006-10-01)

Effects of the Highly COX-2-Selective Analgesic NSAID Etoricoxib on Human Periodontal Ligament Fibroblasts during Compressive Orthodontic Mechanical Strain
od: Christian Kirschneck, i dr.
Izdano: (2019-01-01)

Topical NSAIDs for acute pain: a meta-analysis
od: Mason, L, i dr.
Izdano: (2004)

NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies.
od: Luis Alberto García Rodríguez, i dr.
Izdano: (2011-02-01)

Faecal blood loss: Systematic review and analysis of randomised trials with aspirin and NSAIDs
od: Moore, A, i dr.
Izdano: (2007)

Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond
od: Praveen Rao, i dr.
Izdano: (2008-09-01)

An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
od: Parkinson Lynne, i dr.
Izdano: (2011-11-01)

Non-steroidal anti-inflammatory drugs(NSAIDs) and physiotherapy - a selective review
od: P. van der Bijl, i dr.
Izdano: (2002-01-01)

The effective interplay of (non-) selective NSAIDs with neostigmine in animal models of analgesia and inflammation
od: Mennatallah A Gowayed, i dr.
Izdano: (2021-05-01)

Examining the Risks for NSAID-Induced Gastropathy
od: Sherine E Gabriel, i dr.
Izdano: (1990-01-01)

Impact of NSAIDs on cardiovascular risk and hypertension
od: William B. White, i dr.
Izdano: (2013-03-01)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
od: Harris RE, i dr.
Izdano: (2012-08-01)

Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis
od: Filippo Migliorini, i dr.
Izdano: (2022-07-01)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
od: Straube, S, i dr.
Izdano: (2009)

Exploring COX-Independent Pathways: A Novel Approach for Meloxicam and Other NSAIDs in Cancer and Cardiovascular Disease Treatment
od: Lixia Cheng, i dr.
Izdano: (2024-11-01)

Topical NSAIDs for acute pain: a meta-analysis
od: Derry Sheena, i dr.
Izdano: (2004-05-01)

Pharmacodynamic and Pharmacokinetic Comparison between Selective and Non-selective COX-2 Inhibitors in Mice
od: Taimaa Yahya, i dr.
Izdano: (2024-04-01)

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
od: Alshafie Galal A, i dr.
Izdano: (2006-01-01)

FCERI AND HISTAMINE METABOLISM GENE VARIABILITY IN SELECTIVE RESPONDERS TO NSAIDS
od: Gemma Amo, i dr.
Izdano: (2016-09-01)

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
od: Moore, R, i dr.
Izdano: (2007)

Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2.
od: Haitao Li, i dr.
Izdano: (2013-01-01)

Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures
od: Čeponytė U, i dr.
Izdano: (2018-06-01)

COX ARCHITECTS : Selected and Current Works /
od: Dobney, Stephen, editor 208043, i dr.
Izdano: (1994)

Hartman-Cox : selected and current works /
od: 238867 Hartman, George E., i dr.
Izdano: (1994)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
od: Derry Sheena, i dr.
Izdano: (2009-06-01)